Fujifilm India Pvt Ltd, a pioneer in diagnostic imaging and information systems for healthcare facilities, in association with National TB Elimination Programme (NTEP) started an initiative to increase awareness and eliminate the spread of Tuberculosis in India.
Door-to-door awareness provides an instant interpretation of mobile digital X-rays using Qure.ai’s artificial intelligence solution.
This community-based TB screening initiative will cater to Truckers/Migrant workers, Slum Dwellers/Rural & Semi-urban population in and around industrial pockets in selected areas of 25 districts across states/UT Chandigarh, Punjab, Himachal Pradesh, Uttar Pradesh, Uttarakhand, Bihar, West Bengal, Chhattisgarh, Madhya Pradesh and Rajasthan for the next nine months.
As part of the campaign titled Never Stop: Screening to Reduce Diagnostic Delays, the company aims at increasing awareness on TB and identify individuals having TB symptoms among vulnerable and marginalized sections of the society by introducing a mobile van with an X-ray facility along with a field team and community volunteers.
Through its existing network of labs, the NTEP will help in TB testing and provide TB medicines as per the program guidelines. The International Union Against TB and Lung Disease (The Union), a global leader in lung health, will provide technical support through the United States Agency for International Development’s (USAID iDEFEAT TB Project.
The initiative is also a part of the ‘Corporate TB Pledge (CTP)’, a USAID supported initiative launched with the Government of India in 2019 to galvanize India’s corporate sector to combat TB, raise awareness of TB as a curable disease, and, ultimately, improve TB health outcomes.
The CTP provides corporations with the flexibility to contribute to TB elimination efforts at different levels depending on their resources.
Partnerships
The project has partnered with Apollo Tyres Foundation, Ambuja Cement Foundation, GAIL India and TCI Foundation for on-ground community mobilization, sputum collection, and transportation.
Around nine lac people will be reached through large-scale mid-media activities to identify symptoms for conducting X-ray and subsequent TB testing. Existing CTP partners will facilitate community awareness, mobilization and follow-up testing.
Koji Wada, Managing Director, Fujifilm India Pvt Ltd said, “Tuberculosis is a major and growing health concern in India with many people losing their lives every year. We at Fujifilm have always been committed to providing the best healthcare technologies and innovations to make this world a better and healthier place.”
Dr. Sudarsan Mandal, DDG TB Central TB Division, also added, “India accounts for a quarter of the global TB burden and continues to top the list of patients with tuberculosis, according to a report released by the Global Tuberculosis Report 2020. To control the growing spread of Tuberculosis, we have aligned our efforts by driving conversations leading to an unprecedented increase in TB notifications and improvements in quality diagnostic and treatment. Our association with Fujifilm India is a step ahead in both public and private sectors to strengthen tuberculosis (TB) diagnostic capacity with Fujifilm’s innovative equipment that will ultimately result in an increase in TB cases identification and hence contribute to eliminating TB in the country by 2025.”
